Drug: IFOSFAMIDE. Injury: Hepatocellular injury Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125219471 | IFOSFAMIDE. | Hepatocellular injury | ELI LILLY AND CO | 32.00 YR | F | 0 | 20160701 | GB |
| 125308713 | IFOSFAMIDE. | Hepatocellular injury | PFIZER | 32.00 YR | F | 0 | 20160823 | US |
| 125346562 | IFOSFAMIDE. | Hepatocellular injury | TEVA | 32.00 YR | F | 0 | 20160720 | US |
| 125358341 | IFOSFAMIDE. | Hepatocellular injury | ACTAVIS | 32.00 YR | F | 0 | 20160707 | US |
| 125400462 | IFOSFAMIDE. | Hepatocellular injury | RANBAXY | 32.00 YR | F | 0 | 20160725 | GB |
| 126600711 | IFOSFAMIDE. | Hepatocellular injury | PFIZER | 32.00 YR | F | 0 | 20160817 | US |
Total Records: 6 Number of Pages: 1